Add Yahoo as a preferred source to see more of our stories on Google. The NHS move comes in the wake of the Cass Review, an independent report into transgender services - Alamy/PA The NHS is to launch ...
The MarketWatch News Department was not involved in the creation of this content. OXFORD, United Kingdom and HOUSTON, Jan. 29, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer risk ...
NHS patients with type 2 diabetes (T2D) in England will get earlier access to SGLT-2 inhibitors, now that generics of one of the main drugs in the class – AstraZeneca's Forxiga – are available. Final ...
OXFORD, United Kingdom and HOUSTON, Jan. 29, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer risk assessment, is pleased to announce its selection in a landmark NHS initiative that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results